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Despite clear results of observational studies linking a diet rich in fruits and vegetables to a decreased cancer risk, large
interventional trials evaluating the impact of dietary micronutrient supplementation, mostly vitamins, could not show any
beneﬁcial eﬀects. Today it has become clear that a single micronutrient, given in supernutritional doses, cannot match cancer
preventive eﬀects of whole fruits and vegetables. In this regard polyphenols came into focus, not only because of their antioxidant
potential but also because of their ability to interact with molecular targets within the cells. Because polyphenols occur in many
foods and beverages in high concentration and evidence for their anticancer activity is best for tissues they can come into direct
contact with, ﬁeld cancerization predestines upper aerodigestive tract epithelium for cancer chemoprevention by polyphenols. In
this paper, we summarize cancer chemopreventive attempts with emphasis on head and neck carcinogenesis and discuss some
methodological issues. We present data regarding antimutagenic eﬀects of curcumin and epigallocatechin-3-gallate in human
oropharyngeal mucosa cultures exposed to cigarette smoke condensate.
1.Introduction
About two-thirds of head and neck squamous cell carcino-
mas (HNSCC) can be attributed to heavy tobacco and alco-
hol consumption. These cancers develop predominantly in
men in their sixties [1]. Tobacco carcinogens exert their
harmful eﬀects in large ﬁelds of upper aerodigestive tract
mucosa during decades of smoking. Thus, mucosa cells step-
wise accumulate genetic alterations that drive cells towards
malignancy. Slaughter’s concept of ﬁeld cancerization best
explains head and neck carcinogenesis, that HNSCC patients
often suﬀer from syn- or metachronous cancers and have a
high risk for local recurrences or second primary tumors.
According to this concept, head and neck squamous cell car-
cinomas arise from multifocal precancerous lesions within
large areas/ﬁelds of condemned mucosa in the oral cavity,
pharynx, and larynx [2]. It seems obvious that in the same
manner chemical carcinogens harm the epithelium, preven-
tive agents might protect it. Cancer chemoprevention was
initially supposed by Sporn in 1976. The term describes the
useofspeciﬁcnatural,biologic,orsyntheticagentstoreverse,
suppress, or prevent the development of epithelial cancer.
Sporn reasoned that it usually takes several years until the
ﬁnal, invasive stage of epithelial malignancies is reached.
Therefore, the progression of precancerous lesions could be
stabilized, arrested, or reversed [3]. 10 years later, Hong and
colleagues showed in a landmark study that following treat-
ment with 13-cis-retinoic acid, the size of oral leukoplakia,
a known precancerous lesion of the oral cavity, decreased in
67% of patients given the drug, compared with 10% in the
placebo arm. Moreover, the vitamin A derivate signiﬁcantly
reversed dysplasia [4].
2. Chemopreventionof(HeadandNeck)Cancer
Cancer is a largely preventable disease. Thirty years ago, Doll
and Peto estimated that about 35% of all cancer deaths in the
UnitedStatesofAmericamightbeattributabletodietaryfac-
tors [5]. During the 1980s and 1990s, researchers intensively
investigated the role of dietary factors in upper aerodigestive2 Oxidative Medicine and Cellular Longevity
tract cancers. Multiple case-control studies showed an
inverse correlation between fruit and vegetable intake and
the risk for cancer of the oral cavity and pharynx [6–9]. Peto
et al. also hypothesized in 1981 that β-carotene might reduce
the incidence of all cancers, especially lung cancer [10]. In
1994, evidence had accumulated that β-carotene and the
synthetic retinoid isotretinoin have chemopreventive eﬀects
in multistep ﬁeld carcinogenesis of the upper aerodigestive
tract and lung [11].
In 1988 a large interventional trial was launched includ-
ing more than 18000 men and women at high risk for
lung cancer. The Beta-Carotene and Retinol Eﬃcacy Trial
(CARET) tested the combination of 30mg β-carotene and
25000IU vitamin A/per day against placebo. Surprisingly,
the trial needed to be stopped 21 month, before completion
because of clear evidence of no beneﬁt and substantial evi-
d e n c eo fp o t e n t i a lh a r m f u le ﬀects. There were 28% more
lung cancers and 17% more deaths in the active intervention
group [12].
Another large-scale interventional trial evaluated the
eﬀects of α-tocopherol (vitamin E) and β-carotene on cancer
incidences. The ATBC trial included 29133 male cigarette
smokers randomly assigned to receive α-tocopherol, β-caro-
tene, a combination of both or placebo. Median followup
was 6.1 years. In the β-carotene group, no decrease in cancer
incidences was seen, but rather an increase at several sites,
including the lung and stomach. The vitamin E group
had fewer incidences in prostate and colorectal, but more
stomach cancers [13]. Subgroup analyses for the upper
aerodigestive tract showed no eﬀect of either agent on overall
incidence of oral, pharyngeal, and laryngeal carcinomas or
mortality from these tumors. The results suggested a minor
protective eﬀect of β-carotene on incidences of early stage
larynx cancers [13]. The EUROSCAN study looked for
positive eﬀects of retinyl palmitate (vitamin A) and N-
acetylcysteine on overall survival, event-free survival and
incidence of second primary tumors of head and neck and
lung cancer patients. In 2592 patients, 60% suﬀering from
head and neck, 40% from lung cancer, no beneﬁt for the
intervention group could be shown [14].
After decades of intensive research the scientiﬁc com-
munity ended up with little evidence for beneﬁcial eﬀects,
but clear evidence for harmful eﬀects of micronutrients. In
1999, Byers discussed the reasons why there is this large gap
between the ﬁndings of observational studies and interven-
tional trials. He found several factors that need to be con-
sidered. First, observational studies generally reveal weaker
relationships between cancer and nutrients taken as dietary
supplementation, most probably because of variability in
reportingofdosestakenandpatternsofuse.Second,theran-
domized controlled trials completed followed the investiga-
tional paradigm of pharmacology by testing micronutrients
in supernutritional doses. The basic assumption that high
doses of a single nutrient would reproduce the eﬀects of the
complex mixture of nutrients found in whole foods might
be wrong. But whole foods or whole-diet interventions, he
emphasized, cannot easily be incorporated in those trials,
certainlynotinablindedway.Third,forreasonsoffeasibility,
such trials evaluate only individuals at high risk for cancers
within a short period of time. Since randomized controlled
trials are designed to answer narrowly deﬁned questions, it
may be unwise to study only those at high risk [15].
3. Rationales for Head and
Neck Cancer Chemoprevention
Chemoprevention of head and neck cancer is exceptionally
interestingbecausemanycancersdevelopfrompremalignant
lesions, often readily accessible for clinical and histopatho-
logical examination. Moreover, as a result of ﬁeld cancer-
ization, HNSCC patients are at high risk for local recur-
rences or second primary tumors, an excellent endpoint for
clinical trials. Due to life style factors and health behaviors,
HNSCCpatientsoftenexhibitpoordietaryconditionsbefore
treatment [16]. Besides smoking, the strongest predictor
of survival, low fruit intake, is negatively associated with
survival [17].
Upper aerodigestive tract mucosa is the primary target
of tobacco smoke, a complex mixture of about 7000 chem-
ical compounds including a high concentration of oxi-
dants [18]. One cigarette puﬀ contains 1014–1016 radicals,
mainly reactive oxygen species (ROS) [19]. Thus, cellular
antioxidant defense capacity is easily exceeded leading to
oxidative damage of macromolecules such as proteins, lipids
and DNA. While the former can be replaced during physio-
logical turnover, genetic material needs to be repaired [20].
During carcinogenesis, chemicals and oxidative stress lead to
DNA alterations and evoke an inﬂammatory response that
causes even more oxidative stress [21]. In addition, besides
their intrinsic DNA-damaging properties, elimination of
tobacco carcinogens, causes oxidative stress, not only during
metabolic activation but also by being conjugated with and
thereby depleting glutathione, a major nonenzymic antioxi-
dant of the cell [22]. One of the most frequent ROS-induced
DNA alterations is 8-oxo-guanine, which leads to frequent
misincorporations of adenine in the opposite DNA strand.
The resulting G:C to A:T transversion represents the most
predominant somatic mutations in a wide range of epithelial
malignancies [23]. Hence, tobacco smoke derived oxidative
stress is a major source of DNA damage and mutagenicity.
Therefore, orally administered high doses of potent antiox-
idant micronutrients such as β-carotene, α-tocopherol, or
ascorbic acid in order to compensate oxidative stress seemed
to be the most promising strategy for upper aerodigestive
tract cancer chemoprevention—but, as stated earlier, failed.
On the molecular level, a possible explanation for this
failure is that high doses of antioxidants may have prooxi-
dant eﬀects, as it was supposed by Halliwell for vitamin E
[24]. We showed that vitamin C loses its DNA protective
eﬀects in oxidative stressed cells at high concentrations and
increases DNA damage caused by hydrogen peroxide [25].
4. Polyphenols in Cancer Prevention
In the late 1990s epidemiologists became aware of a phe-
nomenon called the French Paradox. Despite high levels of
risk factors such as smoking, hypertension, diabetes, and
dietary fat, France has a comparably low mortality rate fromOxidative Medicine and Cellular Longevity 3
cardiovascular diseases. This observation was at least partly
explained by high consumption of wine. Pronounced in the
southwest of France, high levels of red wine intake also
seemed to decrease mortality rates from lung cancer [26].
The validity of this conclusion was later questioned because
the protective eﬀect was not seen in other countries with
similar or even higher wine consumption than France, but
much attention was drawn to the potential health beneﬁts
of grapes and wine. Phenolic acids and polyphenols, in total
1.2g per litre red wine, came into focus [27].
5. Resveratrol andTannins
Resveratrol is a natural phenol produced by several plants.
The phytoalexin was detected in high concentrations in
the skin of red grapes and is believed to protect them
from environmental stress and infections. In red wines, its
concentration is approximately 2.0–40.0μM[ 28]. Regarding
HNSCC, only experimental data is available so far. El Attar
and Virji reported in 1999 that resveratrol was eﬀective
inhibiting growth and proliferation of an oral cancer cell
line at concentrations found in red wines [29]. Other studies
proved its eﬀectiveness in preventing intestinal and colon
cancer in rodents. Due to its poor systemic bioavailability,
human interventional trials are diﬃcult to conduct, but at
the moment one study is ongoing regarding possible eﬀects
on colonic mucosa from colon cancer patients [30, 31].
The strongest evidence of anticancer action of resveratrol
exists for tumors derived from tissues with which resveratrol
can come into direct contact [32], thus making it a prime
candidate for HNSCC chemoprevention.
Tanninsarealsofoundinlargequantitiesinredwineand
were shown to act as both anti-initiating and antipromoting
agents in experimental animals [33]. In mouse epidermal
JB6 cells, tannins blocked epidermal growth factor-induced
tumor promotion [34].
6. Quercetin
Quercetin is another polyphenol found in fruits, nuts, herbs,
and vegetables, as well as in wine. It is normally present in
its glycosylated form, but digestive cleavage of the glycosides
catalyzed by β-glycosidases already begins in the oral cavity
[35]. It is a potent scavenger of (oxygen) radicals and
chelator of metal ions involved in ROS production [36], and
it induced the expression of human 8-oxo-guanine DNA
glycosylase, an enzyme involved in the repair of oxidative
damaged DNA, in Caco-2 cancer cells [37]. But, quercetin
is a two-edged sword, because in concentration greater than
40μM, it increased oxidative stress in Chinese hamster ovary
cells[38].ChemopreventiveeﬀectsinmicewereshownbyDe
and colleagues. Orally administered quercetin restricted the
progression of cervical dysplastic lesions [39]. In humans, it
has a comparable poor systemic bioavailability as resveratrol
[30].
7.Epigallocatechin-3-Gallate(EGCG)
Tea is one of the most widely consumed beverages in the
world. Flavanols, commonly referred to as tea catechins,
notably epicatechin, epicatechin-3-gallate, epigallocatechin
and epigallocatechin-3-gallate (EGCG), represent about 3–
10% of the dry weight of black tea and 30–42% of green tea,
respectively. Orally administered, bioavailability of EGCG
wasfoundtobeabout16%inrats.Thereseemstobenocon-
siderable presystemic hepatic metabolism [40]. Even though
antioxidant properties of tea catechins are well established in
vitro [41] ,t h er a t i o n a l ef o rc h e m o p r e v e n t i o nt r i a l si sl a r g e l y
based on its molecular mechanisms. Dong and colleagues
identiﬁed vimentin, insulin-like growth factor 1 receptor
and Ras-GTPase-activating protein SH3 domain-binding
protein 1 as high aﬃnity binding targets for EGCG, all of
which were shown to be involved in EGCG-mediated growth
inhibition in various cancer cell lines [42–44]. Of particular
interest regarding head and neck carcinogenesis, EGCG was
demonstrated to have inhibitory eﬀects on epidermal growth
factor receptor (EGFR) signalling pathways as detected in
esophageal cancer, epidermoid carcinomas and colon cancer
cell lines [45–48]. Further targets of EGCG and molecular
mechanisms of action are reviewed by Yang and colleagues
[49]. Despite these laboratory ﬁndings, a meta-analysis by
the Cochrane collaboration of 51 studies including more
than 1.6 million participants could not ﬁnd suﬃcient
evidence for cancer chemopreventive eﬀects of drinking
(green) tea [50].
8.Curcumin
Curcumin, the yellow pigment in tumeric, is widely used
as a spice and has various properties such as antioxidant,
immunomodulation, antiangiogenesis, and induction of
apoptosis [32]. It was shown to eﬀectively inhibit growth
of normal human oral epithelial cells and cell lines derived
from both oral precancerous lesions and squamous cell car-
cinomas [51]. Moreover, curcumin decreased incidence and
volume of chemically induced oral cancers in rats [52]. In a
prospective trial of patients at high risk for the development
of epithelial cancer in several organs, oral intake of curcumin
up to 8g/day had no toxic eﬀects in humans and led to
histologic improvement of oral leukoplakia in 2 of 7 patients
during 3 months of administration [53]. In 25 patients
with oral leukoplakia treated with 900mg curcumin, 80mg
desmethoxycurcumin and 20mg bisdesmethoxycurcumin
per day, serum and salivary vitamin C and E levels were
foundtoincrease,whilemarkersforoxidativestressinserum
and saliva decreased [54] .I nh e a da n dn e c kc a n c e rc e l ll i n e s ,
curcumin was shown to target various molecular pathways
including caspase-3 dependent signalling, Notch-1 and NF-
κB pathways. This resulted in the induction of apoptosis and
general growth inhibition of the cell lines [55–59].
9. Methodological Considerations
Some theoretical points regarding chemopreventive research
need to be considered. Growth inhibitory or proapoptotic
eﬀects of polyphenols in cancer cell lines do not indicate
chemopreventive, but rather chemotherapeutic eﬀects. The
use of cancer derived cell lines to evaluate possible eﬀects
of polyphenols on various cellular signalling pathways and
protein expression should at least be questioned.4 Oxidative Medicine and Cellular Longevity
In this respect, epidermal growth factor receptor (EGFR)
biology is a good example. About 80–90% of HNSCC show
high expression of EGFR. Since high EGFR levels have been
detected in premalignant lesion and increasing levels were
found during malignant progression, the receptor is a widely
accepted biomarker for head and neck carcinogenesis [60].
This made the receptor an interesting target for chemopre-
vention on the basis of anticipated inhibition of malignant
transformation.
WeinvestigatedtheroleofEGFRbiologyinthecontextof
chemical carcinogenesis caused by benzo(a)pyrene (B(a)p)
and found that EGFR stimulation signiﬁcantly reduces
B(a)p-inducedDNAfragmentationinpremalignantoropha-
ryngeal mucosa cells exhibiting high EGFR expression. This
eﬀect was totally abrogated when the receptor was blocked in
advance [61, 62]. Thus, in premalignant mucosa of head and
neckcancerpatients,EGFRstimulationprotectsthecellfrom
B(a)p, most probably as a result of EGFR downstream acti-
vation of a multidrug resistance eﬄux pump [63] capable of
extrudingthecarcinogenfromthecell[64,65].Furthermore,
evidenceismountingthatEGFRlevelscorrelatewithtobacco
consumption and might, hence, represent a physiological
response to its carcinogenic impact.
On the other hand, in HNSCC EGFR serves as an
independent prognostic marker associated with resistance
to nonsurgical therapies and poor survival [66]. Particularly,
increased EGFR expression was linked to poor response to
platinum-based chemotherapy. Cetuximab, a monoclonal
EGFR antibody, was shown to be eﬀective in cisplatin-
resistant cancers [67]. The very same eﬄux pumps involved
in B(a)p-extrusion are implicated in the resistance to
chemotherapeutic drugs like cisplatin [68]. Named
according to their function in antimicrobial and anticancer
chemotherapy, it has now become clear that these pumps
rather confer a general defense against xenobiotics and are
highly conserved in all living organisms [69].
Therefore, EGFR inhibition, for example, by EGCG,
certainly leads to growth inhibition in cell line experiments
and might render cancer cells more sensitive to cytotoxic
drugs. But it might also diminish cellular defense against
carcinogens in premalignant mucosa. This illustrates thatthe
modiﬁcation of cellular signalling pathways or protein
expression might have a diﬀerent impact in non-/prema-
lignant cells and cancer cells, respectively.
For the above reasons the most appropriate in vitro
model for cancer chemopreventive trials has not yet been
identiﬁed. Animal models show their strength when poten-
tial chemopreventive agents suppress or even reverse arti-
ﬁcially induced malignant transformation of epithelial cell
despite the fact that it is obviously not the primary organism
of interest. In our laboratory we use tissue cultures of
freshbiopsied human upper aerodigestive tract mucosasince
many years. First described by Steinsv˚ ag and colleagues for
nasopharyngeal adenoid tissue [70], we applied the model
for nasal and oropharyngeal mucosa. Samples harvested
during surgery on lower nasal turbinates, palatine tonsils
and soft palate are kept in culture for several weeks until
three-dimensional tissue cubes consisting of a connective
tissuedcoreandcompletelycoatedwithciliatedorsquamous
epithelium have emerged. For the evaluation of carcinogenic
impact of xenobiotics on upper aerodigestive tract mucosa,
mostly isolated mucosa cells are applied. Compared to cells
kept in their surrounding tissue, however, single cells may
haveonlyalimitedmetaboliccompetence,notonlyforxeno-
biotics but also for endogenous-derived compounds. More-
over,singlecellsarenotbestsuitedforrepetitivetestsbecause
ofconsiderablelossofcellularmaterial.Asmentioned above,
head and neck carcinogens strike their targets in a chronic
manner. Nasal or oropharyngeal mucosa cultures can easily
be exposed to multiple incubations with xenobiotics without
considerable cellular damage in terms of viability and can be
transferred by careful aspiration between containers without
cellular loss. Moreover, in these tissue cultures, primary
mucosa cells survive for several weeks. Therefore, our tissue
culture model represents the primary target tissue of inhaled
or ingested xenobiotics and carcinogens. It allows repetitive
incubationsnotonlywithchemicalcarcinogensbutalsowith
chemopreventive compounds [71].
10. DNA Protection by Polyphenols in
HumanMucosa TissueCultures
A carcinogen is deﬁned as a physical, chemical, or biological
agent or a combination of agents that produces cancer in an
organism. The International Agency for Research on Cancer
(IARC) recently classiﬁed tobacco smoke as carcinogenic to
humans (group 1) [72]. This classiﬁcation also applies for
benzo(a)pyrene (B(a)p), which was recently upgraded from
group 2B (possibly carcinogenic to humans)t og r o u p1[ 73].
The majority of known chemical carcinogens are also muta-
gens, hence, agents that produce a genetic event resulting
in a heritable genetic change [74]. B(a)p and its activated
metabolite benzo(a)pyrene diol epoxide (BPDE) are well-
known mutagens [75]. BPDE binds to DNA in vitro and
in vivo and forms adducts, particularly within the p53 tumor
suppressor gene [76]. As described above, oxidative stress
also leads to DNA alterations. Although hydrogen peroxide,
widely used to induce oxidative stress, causes DNA damage
in vivo and in vivo [77], IARC found only inadequate evi-
dence for its carcinogenicity in humans and limited evidence
for carcinogenicity in experimental animals, therefore classi-
fying it as group 3 (not classiﬁable as to its carcinogenicity to
humans)[ 78].
Using nasal and oropharyngeal mucosa tissue cultures,
we previously evaluated the ability of epigallocatechin-3-
gallate (EGCG), tannins, and quercetin to prevent DNA
damage. Cultures were incubated with the polyphenols
before DNA was damaged by cigarette smoke condensate
(CSC),BPDE,orhydrogenperoxide.Genotoxicitywasquan-
tiﬁed by the comet assay. To test EGCG, oropharyngeal
mucosa cultures were incubated with EGCG before DNA
fragmentation was introduced by BPDE, which was pre-
viously shown to induce dose-dependent DNA migration
detectable by the comet assay in human cells [79]. The
treatmentwithEGCGsigniﬁcantly decreasedBPDE-induced
DNAdamageinadose-dependentmanner.Inafurtherseries
of tests, tissue cultures were incubated with EGCG on only
1 or on 4 days for 30 minutes. DNA damage was inducedOxidative Medicine and Cellular Longevity 5
by CSC during an 18-hour-incubation period. Here, DNA
damage was decreased by 28% after 1 and by 47% after 4
incubations [80]. Similar results were seen when cultures
were exposed to tannins during 30 minutes on 3 days. DNA
fragmentation caused by BPDE went down by more than
40% [81].
In cultures produced of nasal mucosa quercetin signiﬁ-
cantly prevented DNA damage caused by hydrogen peroxide,
again in a dose-dependent manner [82].
For the study presented here we used oropharyngeal
mucosa. Cultures were incubated with curcumin, EGCG or
both. DNA damage was introduced by cigarette smoke con-
densate and quantiﬁed using the comet assay.
11.MaterialsandMethods
11.1. Tissue Material. The trial was approved by the ethics
committee of Ludwig-Maximilians-University, Munich, Ger-
many. After given informed consent, mucosa samples were
harvested during surgical therapy of chronic tonsillitis
and/or obstructive sleep apnoea syndrome. Tissue samples
were obtained during tonsillectomy and uvulopalatopharyn-
goplasty. After excision, samples were covered with 0.9%
NaCl solution.
11.2. Cell Culture Procedure. After immediate transport to
the laboratory, specimens were dissected into mucosal cubes
of 1mm3 excluding deeper layers. Specimens were then
transferred into a tube containing 5mL Phosphate Buﬀered
Salina (PBS, Gibco invitrogen, Eggenstein, Germany),
washed three times in PBS, and placed in 24-well plates, one
fragment in each well. Bottoms of wells were coated with
30mL 0.75% Agar Noble (DIFCO, Detroit, USA) dissolved
in 30mL Dulbecco’s modiﬁed eagle medium (DMEM), 6mL
10%fetalcalfserum(Gibco),75μLnonessentialaminoacids
(Gibco), 240μL penicillin-streptomycin (Sigma Aldrich,
Steinheim, Germany), and 120μL amphotericin B (Gibco),
thus preventing adhesion to the surface. Cultures were
now covered with 250μL Bronchial Epithelial Cell Growth
Medium (BEGM, supplemented with Bovine Pituitary
Extract, insulin, hydrocortisone, epinephrine, triodothyro-
nine, transferring, and retinoic acid; Promocell; Heidelberg,
Germany) per well. After about 21 days incubated at 37◦C,
5% CO2, and 100% relative humidity, mucosa cultures were
completely coated with epithelium. Growth medium (250μL
BEGM) was renewed every second day; every seventh day
multiwell plates were changed. When transferred, cultures
were mildly aspirated with a pipette, thus preventing damage
to the cells as far as possible.
11.3. Incubations. In a ﬁrst experimental arm, 20 mucosa
cultures were incubated with 1μmol/L curcumin for 60 min-
utes on 1 or 4 consecutive days. The concentration was
determined by dose-response experiments (data not shown).
BEGM was replaced twice after all incubations. Directly after
the last incubation, cultures were exposed to cigarette smoke
condensate (CSC, 0.7mg/mL; produced of Marlboro Fla-
vor Mix; Analytisch-Biologisches Forschungslabor, Munich,
Germany) for 18 hours. All reagents were solved in dimethyl
sulfoxide (DMSO, Merck, Darmstadt, Germany), which was
used as negative control. In a second experimental arm,
20 cultures were exposed to 1μmol/L curcumin for 1 hour
and 0.5μmol/L EGCG for 30 minutes to evaluate possible
synergistic eﬀects. Again, CSC was incubated for 18 hours.
11.4. Comet Assay. To quantify resulting DNA damage the
alkaline version of the single cell microgelelectrophoresis
(comet assay) was applied. The assay is capable of detecting
DNA double- and single-strand breaks as well as alkaline
labile sites and transient repair sites [83].
Mucosa cultures underwent enzymic digestions for 1
hour after being covered with a solution of 50mg protease
(Biochrom, Heidelberg, Germany), 10mg hyaluronidase
(Roche, Mannheim, Germany), and 10mg collagenase P
(Roche) dissolved in 10mL BEGM. Thereafter, connective
tissue and extracellular matrix components were carefully
removed. Histolytic enzymes were neutralized with fetal calf
serum (Gibco), and the cell suspension was washed twice in
cold PBS (Gibco). Cell viability was monitored by the trypan
blue dye exclusion test.
Comet assay was carried out according to the standard
protocol[84].DNAmigrationwasmeasuredusingtheimage
analysis software Komet 3.1 (Kinetic Imaging, Liverpool,
UK) and quantiﬁed by the percentage of DNA in the tail
(% tail DNA) [85]. 80 cell nuclei per slide were randomly
selected without knowledge of pretreatment.
11.5. Statistical Analysis. Signiﬁcant diﬀerences in DNA
damage were calculated using the Wilcoxon Signed-Rank
test by the SPSS 18.0 software (SPSS GmbH, M¨ unchen,
Germany).Alphalevelwassetat0.05priorstatisticalanalyses
and adjusted according to the Bonferoni correction because
of multiple testing. Signiﬁcant α-levels are indicated in
ﬁgures.
12. Results
Cell viability veriﬁed using the trypan blue staining test was
constantly >90%, thus excluding major cytotoxic eﬀects of
the substances tested.
In the ﬁrst experimental arm, DMSO used as the solvent
for all other chemicals, as well as curcumin added on 1 or
4 days, did not cause considerable DNA damage. CSC did
induce DNA fragmentation mean % tail DNA was 19.1.
Previous exposure to curcumin within 60 minutes led to a
reduction of DNA damage by 31.4% to 13.1% tail DNA.
When cultures were incubated with curcumin on 4 days,
DNA fragmentation was reduced by 47% to 10.1% tail DNA,
which reﬂects a signiﬁcant further decrease of CSC-induced
genotoxicity (see Figure 1).
These results were conﬁrmed in the second experimental
arm. Again, the solvent, curcumin, and EGCG did not cause
DNA fragmentation (data not shown). Curcumin decreased
CSC-induced DNA fragmentation by 25.8% (1 day) and
47.1% (4 days), respectively. EGCG added on 1 or 4 days
did also signiﬁcantly reduce CSC-caused genotoxicity. % tail
DNA went down from 24.0 to 18.8 (21.7%) and to 13.8,
respectively (42.5%; see Figure 2).6 Oxidative Medicine and Cellular Longevity
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Figure 1: DNA damage (% tail DNA) caused by cigarette smoke
condensate (CSC), after previous incubation with Curcumin on 1
day or on 4 days (n = 20; o = outlier value, ∗ = extreme value; α-
level = 0.02).
Both polyphenols added together did not show syner-
gistic eﬀects. When incubated in 1 day, the combination of
both substances did not further increase the eﬀect of both
curcumin and EGCG, but still signiﬁcantly reduced genotox-
icityofCSC.Whenaddedon4days,thecombinationofboth
substances did no longer signiﬁcantly reduce CSC-induced
genotoxicity after α-level was set to 0.006 according to the
Bonferoni correction (see Figure 2).
13. Conclusion
Inourstudy,mucosacultureswereincubatedwithcurcumin,
epigallocatechin-3-gallate (EGCG), or both on 1 day or on 4
consecutive days. After all incubations, the growth medium
was replaced twice. Finally cultures were exposed to cigarette
smoke condensate (CSC) for 18 hours. The result was a
highly signiﬁcant reduction of CSC-caused genotoxicity as
evaluated by the comet assay in all experiments except for
the combination of curcumin and EGCG incubated on
4 days. No additive eﬀects were detected when curcumin
and EGCG were added simultaneously. Compared to the
other polyphenols tested in our laboratory, curcumin was
most eﬀective preventing tobacco-related DNA damage. All
compounds reduced genotoxic eﬀects of B(a)p or CSC in a
dose-dependent manner [80, 81].
Bearing in mind that tobacco smoke is carcinogenic to
humans and responsible for the vast majority of head and
neck cancers, our results demonstrate promising chemo-
preventive potentials of curcumin and EGCG. Since we
used oropharyngeal mucosa cultures as a primary human
target tissue of tobacco smoke, the experimental setting
represents a good compromise between in vivo studies in
animals and human cell line experiments. Taken together,
this study and previous results of our laboratory indicate
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Figure 2: DNA damage (% tail DNA) caused by cigarette smoke
condensate (CSC), after previous incubation with curcumin,
epigallocatechin-3-gallate (EGCG), or both, on 1 day or on 4 days
(n = 20; o = outlier value; α-level = 0.006).
that dietary polyphenols are capable of preventing tobacco-
related genotoxicity in upper aerodigestive tract mucosa. A
diet high in fruits and vegetables remains the major source of
polyphenoliccompoundsandwasrepeatedlyshowntolower
the risk for HNSCC. Unfortunately, many heavy smokers do
not exploit this source due to life-style habits.
Despitethedisappointingﬁndingsoflargeinterventional
trials evaluating the impact of dietary micronutrient sup-
plementation, mostly vitamins, on cancer incidences, the
clear results of observational studies remain valid. Even if it
could not be shown that one single agent or a combination
of two can be as eﬀective as whole fruits and vegetable,
it is still in this diet and therefore a matter of time, until
the network and interactions of micronutrients involved are
better understood. Vitamin E, for example, is a complex
mixture of 16 chemical compounds including 4 tocopherols.
In the western diet, the most prevalent vitamin E compound
is γ-tocopherol and high serum levels were shown to be
inversely associated with cardiovascular diseases. Gamma
Tocopherol is poorly retained after intestinal absorbtion,
and α-tocopherol, widely used for dietary supplementation,
reduces further serum concentration of γ-tocopherol [86–
88]. Moreover, several vitamins in high supernutritional
doses might be more harmful than protective. The old
sentence of Paracelsus “dosis facit venenum” seems to be
particularly true in this regard.
It becomes clear that micronutrient supplementation
cannot mimic a diet rich in whole fruits and vegetables.
P o l y p h e n o l sr e c e n t l yc a m ei n t of o c u s ,n o to n l yb e c a u s eo f
their powerful antioxidant eﬀects but also because of their
ability to interact with cellular signalling pathways. In this
regard, as stated above, we need to carefully distinguishOxidative Medicine and Cellular Longevity 7
chemopreventive and rather chemotherapeutic eﬀects.
Nevertheless, polyphenols showed promising anticancer
and antimutagenic action. The fact that several phenolic
compounds are present in beverages in high concentrations
makes them good candidates for head and neck cancer
chemoprevention. Since evidence for anticancer eﬀects is
best for tissues they can come into direct contact with, upper
a e r o d i g e s t i v em u c o s a ,t a r g e to fﬁ e l dc a n c e r i z a t i o n ,s e e m st o
be one of the best-suited tissues.
Abbreviations
HNSCC: Head and neck squamous cell carcinoma
ROS: Reactive oxygen species
EGCG: Epigallocatechin-3-gallate
EGFR: Epidermal growth factor receptor
B(a)p: Benzo(a)pyrene
BPDE: Benzo(a)pyrene diol epoxide
CSC: Cigarette smoke condensate.
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